Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 50,205 | 49,757 | 61,256 | 89,057 | 58,856 |
| Gross Profit | 50,205 | 49,757 | 61,256 | 89,057 | 58,856 |
| Operating Expenses | 12,709 | 75,235 | 69,742 | 78,660 | 60,085 |
| Operating Income | 37,496 | -25,478 | -8,486 | 10,397 | -1,229 |
| Interest Expense | 3,555 | 3,440 | 3,284 | 3,427 | 3,557 |
| Other Income | 4,864 | 4,019 | 5,378 | 4,931 | 5,032 |
| Pre-tax Income | 38,805 | -24,899 | -6,392 | 11,901 | 246 |
| Income Tax | 1,034 | -399 | 235 | 385 | 30 |
| Net Income Continuous | 37,771 | -24,500 | -6,627 | 11,516 | 216 |
| Net Income Discontinuous | -99,646 | 8,919 | 843 | -606 | -10,822 |
| Net Income | $-61,875 | $-15,581 | $-5,784 | $10,910 | $-10,606 |
| EPS Basic Total Ops | -0.53 | -0.13 | -0.05 | 0.09 | -0.09 |
| EPS Basic Continuous Ops | 0.32 | -0.21 | -0.06 | 0.10 | 0.00 |
| EPS Basic Discontinuous Ops | -0.85 | 0.08 | 0.01 | -0.01 | -0.09 |
| EPS Diluted Total Ops | -0.53 | -0.13 | -0.05 | 0.09 | -0.09 |
| EPS Diluted Continuous Ops | 0.32 | -0.21 | -0.06 | 0.10 | 0.00 |
| EPS Diluted Discontinuous Ops | -0.85 | 0.08 | 0.01 | -0.01 | -0.09 |
| EBITDA(a) | $46,495 | $-9,462 | $8,908 | $27,077 | $15,516 |